CANF

Can-Fite BioPharma
CANF

Overview Fund Trends Analyst Outlook Journalist POV

13 hedge funds and large institutions have $186K invested in Can-Fite BioPharma in 2024 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

less ownership

Funds ownership: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

88% less capital invested

Capital invested by funds: $1.52M → $186K (-$1.33M)

Holders
13
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$40.9K
2
+$16.1K
3
+$5.53K

Top Sellers

1
-$1.31M
2
-$29.5K
3
-$16.5K
4
Osaic Holdings
Osaic Holdings
Arizona
-$8
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$52.8K
2
$43.7K
3
$40.9K
4
$31.5K
5
$5.53K
6
$4.88K
7
$4.06K
8
$975
9
$899
10
$325
11
$293
12
$32
13
$2
14
–